The Beloit, Wisconsin-based firm, known for producing molybdenum-99, is working with Chicago's Monopar Therapeutics on the treatment to battle severe cases of the disease.
The health system giant's Center for Multiple Sclerosis, along with additional institutions, will test if central vein sign can help clinicians diagnose the condition via MRI.
The French Society of Neuroradiology examined 37 consecutive patients’ neurological imaging findings from 16 different centers for their study published earlier this month.
“Black lives matter. The need to speak out against racism, racial injustice and inherent bias compels each of us as leaders in our community to act,” Founder and CEO Greg Piefer said in a recent message to employees.
Doctors involved in the study, who presented during the Society of Interventional Radiology's virtual meeting, say the augmented-reality platform can help physicians and patients better understand their treatment.
With further refinement, the researchers say their convolutional neural network-based platform could help lighten sonographers’ ever-increasing workloads.
Clinicians use the device to image blood flow dynamics during retinal exams, helping them spot age-related macular degeneration, diabetic retinopathy, and retinal vein occlusions.
About 80% of physicians requested an extra set of eyes from an outside facility either “always” or “most of the time,” and more than 90% said such consultations improved care.
TeraRecon EnvoyAI and Northstar technologies are renamed with SymphonyAI Group shared branding in the next step toward connecting B2B systems of intelligence for improved care.